Navigation Links
Tumor size and level of visceral pleura invasion can impact survival of NSCLC patients
Date:8/19/2009

AURORA, CoA study published in the August 2009 edition of the Journal of Thoracic Oncology found that non-small cell lung cancer (NSCLC) patients could be more accurately staged at diagnosis by taking into account the level of visceral pleura invasion (VPI). VPI is the extension of a tumor beyond the elastic layer of the visceral pleura.

Researchers from the National Cancer Center East in Kashiwa, Japan conducted a review of data from the Japanese Joint Committee for Lung Cancer Registration. After examining the records of 9,758 patients who underwent surgical resection in 1999, the patients were divided into nine groups based on tumor size and VPI.

The status of disease progression is determined through staging by measuring the presence of a localized tumor (T Status), presence of cancerous cells in the lymph nodes (N status) and metastasized tumors (M status). The TNM classification has several subgroups, or stages, that allow physicians to pinpoint the most accurate level of disease progression and develop a treatment plan. Using the International Association for the Study of Lung Cancer's staging model, Junji Yoshida, MD and his team concluded that a tumor 7cm or less with VPI should be upgraded to the next stage in T status.

"This research is extremely necessary in order to fine tune the lung cancer staging guidelines and be sure patients receive the most accurate staging and treatment," said Dr. Yoshida. "Accurate staging and course of treatment can impact the patient's prognosis tremendously."


'/>"/>

Contact: Bethany Fischer
bfischer@spectrumscience.com
202-955-6222
International Association for the Study of Lung Cancer
Source:Eurekalert

Page: 1

Related medicine news :

1. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
2. Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells
3. Study details regulation of vital tumor suppressor gene p53
4. Human C-reactive protein regulates myeloma tumor cell growth and survival
5. Customized virus kills brain tumor stem cells that drive lethal cancer
6. Study suggests brain tumors need treatment with multiple targeted drugs
7. Bright tumors, dim prospects
8. National Brain Tumor Foundation Unites with BrainLAB in Support of Patient Education
9. Discovery of widespread tumor growth gene holds promise for effective anti-cancer treatment
10. PET scans can accurately detect a breast tumors response to chemotherapy
11. DNA damage response confers a barrier for viral tumorigenesis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... ... ... from Greet, S.C., wants to offer people a new way to care for their feet. ... so I know the importance of proper foot care," he said. "In order to enable ... The FOOT-TRAN SYSTEM enables a user to clean and exfoliate the bottoms of his or ...
(Date:3/29/2017)... ... 2017 , ... ARI Network Services, Inc. (NASDAQ: ARIS) announced today that Rhino ... its network of more than 650 U.S.-based dealers. Rhino, a member of the Alamo ... flail mowers and cutters, rear blades, post hole diggers, pasture renovators, tillers, disc mowers ...
(Date:3/29/2017)... ... March 30, 2017 , ... CHARM CITY RUN WELCOMES MERCY ... announced that Mercy Medical Center will serve as the official title sponsor of the ... Sunday, June 25, 2017, thousands of women will walk or run the course around ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... at a Walgreens store in Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest and ... two southeastern states. Ingredients in HeartBoost, an over the counter heart healthy drink, ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... as it continues developing an ANSI-approved, consensus-based American National Standard for Good ... to publish the first ANSI-approved GMP standard for dietary supplements this spring, ...
Breaking Medicine News(10 mins):
(Date:3/30/2017)... 2017 The new research portal ... comprehensive collection of company reports on UnitedHealth Group ... of their activities in the healthcare industry. ...      ... is going through a fundamental transformation globally-a shift from ...
(Date:3/30/2017)... Julie & Lefkowitz LLP, a class action law firm dedicated ... fiduciary duty claim involving the board of directors of Synergy ... If you are a shareholder of Synergy Pharmaceuticals and are ... charge, please visit us at: ... http://pjlfirm.com/synergy-pharmaceuticals-inc/ ...
(Date:3/29/2017)... Mar. 29, 2017 Research and Markets has ... report to their offering. ... The global gas chromatograph market to grow at ... The report, Global Gas Chromatograph Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
Breaking Medicine Technology: